S100A11 and breast cancer: In addition, although genetic alterations of S100A11 were not found to be linked to the OS of patients with BC (Fig. 5C), the S100A11 mutation group was associated with poorer DFS, DSS, and PFS for BC patients compared to the group without mutations (Fig. 5D–F).